Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity
about
P1343
Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges.Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.Mining human antibody repertoires.Advances in the Isolation of Specific Monoclonal Rabbit Antibodies.Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell linesA fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses.Monoclonal lupus autoantibody secretion by human-human hybridomas. Selection of hybrids by conventional and novel techniquesImmortalisation of human antibody producing cells.Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigens.Human monoclonal antibodies to lung-cancer antigensTreatment of human cell lines with 5-azacytidine may result in profound alterations in clonogenicity and growth rate.Production of human monoclonal IgG antibodies against Rhesus (D) antigen.Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell linesHuman hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual.Immunization of mice against African trypanosomiasis using anti-idiotypic antibodiesUse of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.Mutant monoclonal antibodies with alterations in biological functionsAntibody producing human-human hybridomas. II. Derivation and characterization of an antibody specific for human leukemia cells.Immunological probes in cardiovascular disease.Protective human hybridoma antibody to tetanus toxin.Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization.Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.Generation of human monoclonal antibodies reactive with cellular antigens.UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.Characterization of human hybridomas secreting antibody to tetanus toxoid.Potential applications of monoclonal antibodies in cancer diagnosis and therapy.Drug delivery systems--2. Site-specific drug delivery utilizing monoclonal antibodies.Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.Monoclonal antibodies in oncology.An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodiesProspects for human monoclonal antibodies: a critical perspective.Immunologic aspects of melanoma.Immunobiological determinants in organ transplantation.Some properties and applications of monoclonal antibodies.Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.Beneficial effects of human viruses.The IgG binding site of human FcgammaRIIIB receptor involves CC' and FG loops of the membrane-proximal domain.Inhibitors of renin: present and future.
P2860
Q33224048-96C5649F-B470-49E0-BE77-335CC4F50FCBQ33514828-24443E33-4437-46C7-A86A-AE2B26B065BFQ33588489-2DBD0393-2F03-4CD0-AC91-9E715BC8120FQ33639031-3C2A29E9-7F48-4D2E-8D3A-80E65AA6F95FQ34081748-D632E655-F257-47C7-A22B-91FEE2537A5AQ34660961-8E079C1D-B431-4AE7-9AFA-F588FFAA86C1Q35161714-83A2CF1D-2190-41C1-AD07-F11AE9394B3FQ35208089-E516EC9E-A84D-407F-9BC6-6D24CAC9DDBFQ35237160-660AA004-9327-43E0-A901-C0AA638BE9E1Q35602952-137F2C90-9E9E-4C01-8372-7C8C2A16DA89Q36045303-3E6FF39B-3724-4AE9-9FA3-CCB14EA724DFQ36211624-EE463DD7-5A5C-4C65-BC33-CE966F61CA09Q36261759-CE417484-9A32-43BC-BBEE-096502738A12Q36312546-B3CFC540-7E08-404D-8169-D6EA1252E5D1Q36319158-AB5B8E37-9EF7-45B2-AA17-700A76248E7AQ36346048-BA883F71-04CB-4D87-B22B-8E4089F2CBEBQ36346325-A2179F5D-83F4-4F94-97DB-585F824F0722Q36346858-891B846B-F1BB-41E8-838B-3652EF6B160FQ36347048-D0F3166B-5B1B-4F34-B17E-2FF947A08513Q36348484-246D4EE0-F38F-46E7-8CAA-14967FF98FA4Q36737262-01C78400-0E5E-44FC-B8AA-A58B89F963B7Q36988834-BF4269A8-B65D-4B04-9C5E-3D22779B82ECQ37343139-6D821137-55E4-4759-886A-1FE896178B40Q37509769-4140FA9E-B143-4500-95A3-E6C4F7A5B488Q37608089-6157E255-2A73-4ECE-B4EB-FD4C6F32C1F0Q37618105-B4CE5FE1-78BA-436C-B055-185BBE37C26AQ37618342-597A1C12-5CD7-4B16-B863-A91B52779CF5Q38157384-952C0405-D385-4BE2-BABC-DC431FEA2C47Q38731784-50000C7D-7E74-4BBE-8FCA-D4109932E719Q38922319-6262E09F-D12E-4C8A-BFF7-CC17826A883AQ39488591-75654E8A-FC87-48A9-86FC-C98DC26EBC22Q39976828-9BF7CB9C-C26B-4C79-AF88-978CEA1A87ADQ40132669-8A445DF7-3901-479C-8576-0EE792A902A8Q40132910-FA3655CD-1A83-406E-8F6C-BA1780029BE7Q40150649-7D3D1362-6F75-47AC-9EE6-82CF615F0C5CQ40325334-70CF4A23-3794-4C27-BED2-2878D1064CB4Q40511607-DA3EA7D8-2E1B-4775-9A52-616C363547EBQ41197743-1DDA534B-6D2C-4D59-B794-8341C1C23396Q41227547-0B0472FE-82FB-4320-AD0A-6CE250A17F1CQ41452341-C996CEE7-FC53-41CC-AB84-17A2F685025C
P2860
Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Human-human hybridomas produci ...... edefined antigenic specificity
@ast
Human-human hybridomas produci ...... edefined antigenic specificity
@en
type
label
Human-human hybridomas produci ...... edefined antigenic specificity
@ast
Human-human hybridomas produci ...... edefined antigenic specificity
@en
prefLabel
Human-human hybridomas produci ...... edefined antigenic specificity
@ast
Human-human hybridomas produci ...... edefined antigenic specificity
@en
P2860
P356
P1476
Human-human hybridomas produci ...... edefined antigenic specificity
@en
P2093
P2860
P304
P356
10.1073/PNAS.77.9.5429
P407
P4510
P577
1980-09-01T00:00:00Z